Company Updates
FINEXIA Direct Accommodation Income Fund Pays Distribution to Investors
Finexia Financial Group Limited (FNX) is pleased to announce that its flagship wholesale managed fund, the “Finexia Direct Accommodation Income Fund” (FDAIF), which was launched in September 2021, has
AXIchain partnering for success with DLL
AXIchain is pleased to announce it is partnering with De Lage Landen (DLL) to combine the
technology solutions of AXIchain and the financial power of DLL to provide livestock finance to
AXIchain custo
Leading Australian crypto exchange Coinstash launches a waitlist for flagship product, Coinstash Earn. Receive up to 8% on USD and 6% AUD stablecoin deposits through Coinstash.
Coinstash is an up-and-coming crypto platform set to disrupt the Australian financial services industry by delivering highly competitive yields on cryptocurrency, including USD and AUD stablecoins. Co
The City of Las Vegas unveils advanced Digital Twin at Consumer Electronics Showcase (CES)
Cityzenith’s ambitious project to help Las Vegas building owners transition to net-zero carbon emissions has completed its first stage.
The Las Vegas Digital Twin project encompasses a 7 sq km area o
Crypto (DeFi) Focused Systematic Investment Fund and Platform with a 90% Customer Retention Rate | Average Return of 23.10%
Gembot is a FinTech and Fund with an AI investment platform that democratises investment strategies and tools for consumers.
Paperless B2B Trader Collaboration Platform | $1.7T of Unmet Trade Finance Demand | CEO Represents Australia in International Organisations
“NeXTRADE’s mission, research, and services directly align with the World Customs Organisation (WCO) vision to modernise the core, connect digital and physical realities, and expand the horizon.
A
EPIAXIS Expands Its PKC Theta Pre-clinical Program
EpiAxis Therapeutics is pleased to announce it is commencing a pre-clinical collaboration focused on inhibiting Protein Kinase C theta (PKC theta), which could provide a potential new approach to trea
Horizon 3 Welcomes Dr.Tam Nguyen As Part of the Investment Committee
“Horizon 3 Biotech is excited to announce the addition of Dr.Tam Nguyen to our Investment Committee. Tam is a Non-Executive Director and Deputy Director of Research with over 15 years of board level e
Full-Fibre ISP with Customer Base Growing at 10% Per Month | Top 10 Potential
The UK consumer has been struggling with poor speeds, unreliable copper connections and mediocre customer service from faceless organisations for many years, as the government and Ofcom often highligh
Backed By Leading Investment Groups and Family Offices
